Влияние вторичной миелодисплазии на выживаемость пациентов со злокачественными лимфомами
Дьячкова Наталья Юрьевна, Igor Borisovich Kovynev, Elena Nikolaevna Voropaeva et al. · Сибирский научный медицинский журнал · 2011
103 patients with lymphoma have been examined, they were divided into two groups: one group without signs of myelodysplasia prior to treatment (n = 36), the second with dysplastic changes in bone marrow (n = 67). It has been shown that survival rates in two groups and the effectiveness of the therapy significantly differ. Cytomorphologic signs of bone marrow dysplasia can be used for lymphoma progression prognosis and treatment refractoriness.
Cited by 0 works.